Lotus Pharmaceutical Co Ltd Cash Flow Conversion Efficiency

Latest as of June 2026: 0.029x

Lotus Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Lotus Pharmaceutical Co Ltd (1795) has a cash flow conversion efficiency ratio of 0.029x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$701.37 Million ≈ $22.10 Million USD) by net assets (NT$24.31 Billion ≈ $765.75 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Lotus Pharmaceutical Co Ltd (2009–2025)

Cash flow conversion efficiency of Lotus Pharmaceutical Co Ltd from 2009 to 2025. This chart illustrates how Lotus Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 1795 stock price and chart for real-time trading data and today's change.

Lotus Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained

Lotus Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Lotus Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Lotus Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see Lotus Pharmaceutical Co Ltd market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Sitio Royalties Corp. NYSE:STR	0.026x
Zhongman Petro & Natural Gas SHG:603619	0.126x
Metrics Master Income Trust AU:MXT	0.036x
VIVENDI UNSPON.ARD EO 55 F:VVUD	N/A
Hexing Electrical Co Ltd SHG:603556	0.023x
Wam Leaders Ltd AU:WLE	0.048x
Yulon Finance Corp TW:9941	0.082x
Castellana Properties Socimi MC:YCPS	0.041x

Annual Cash Flow Conversion Efficiency for Lotus Pharmaceutical Co Ltd (2009–2025)

The table below shows the annual cash flow conversion efficiency of Lotus Pharmaceutical Co Ltd from 2009 to 2025. Review free cash flow generation of Lotus Pharmaceutical Co Ltd to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$23.78 Billion ≈ $749.20 Million	NT$7.48 Billion ≈ $235.72 Million	0.315x	+8.27%
2024-12-31	NT$21.18 Billion ≈ $667.30 Million	NT$6.15 Billion ≈ $193.91 Million	0.291x	+212.04%
2023-12-31	NT$17.33 Billion ≈ $546.10 Million	NT$1.61 Billion ≈ $50.86 Million	0.093x	-65.28%
2022-12-31	NT$13.87 Billion ≈ $436.91 Million	NT$3.72 Billion ≈ $117.18 Million	0.268x	+2380.88%
2021-12-31	NT$11.07 Billion ≈ $348.73 Million	NT$119.66 Million ≈ $3.77 Million	0.011x	-95.15%
2020-12-31	NT$8.75 Billion ≈ $275.53 Million	NT$1.95 Billion ≈ $61.39 Million	0.223x	+469.83%
2019-12-31	NT$7.74 Billion ≈ $243.97 Million	NT$302.81 Million ≈ $9.54 Million	0.039x	-62.31%
2018-12-31	NT$7.68 Billion ≈ $241.98 Million	NT$796.98 Million ≈ $25.11 Million	0.104x	+34.84%
2017-12-31	NT$7.70 Billion ≈ $242.50 Million	NT$592.29 Million ≈ $18.66 Million	0.077x	-47.82%
2016-12-31	NT$8.36 Billion ≈ $263.42 Million	NT$1.23 Billion ≈ $38.85 Million	0.147x	+19.48%
2015-12-31	NT$8.73 Billion ≈ $275.06 Million	NT$1.08 Billion ≈ $33.95 Million	0.123x	+205.33%
2014-12-31	NT$8.81 Billion ≈ $277.59 Million	NT$-1.03 Billion ≈ $-32.53 Million	-0.117x	-81.88%
2013-12-31	NT$1.49 Billion ≈ $46.87 Million	NT$-95.84 Million ≈ $-3.02 Million	-0.064x	+24.60%
2012-12-31	NT$637.28 Million ≈ $20.08 Million	NT$-54.45 Million ≈ $-1.72 Million	-0.085x	+33.24%
2011-12-31	NT$596.05 Million ≈ $18.78 Million	NT$-76.29 Million ≈ $-2.40 Million	-0.128x	-239.89%
2010-12-31	NT$646.95 Million ≈ $20.38 Million	NT$59.19 Million ≈ $1.86 Million	0.091x	-53.31%
2009-12-31	NT$456.73 Million ≈ $14.39 Million	NT$89.50 Million ≈ $2.82 Million	0.196x	--

About Lotus Pharmaceutical Co Ltd

TW:1795 Taiwan Drug Manufacturers - Specialty & Generic

Market Cap

$1.40 Billion

NT$44.57 Billion TWD

Market Cap Rank

#7200 Global

#228 in Taiwan

Share Price

NT$167.50

Change (1 day)

-2.90%

52-Week Range

NT$167.50 - NT$363.00

All Time High

NT$363.00